STOCK TITAN

IBEX CFO has 3,293 shares withheld for taxes

The tax withholding followed restricted-stock vesting, with direct holdings reported at 60,435 common shares afterward.

(High)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

IBEX Ltd Chief Financial Officer Taylor C. Greenwald had 3,293 common shares withheld for tax purposes upon vesting of a restricted stock grant on September 18, 2026. The reported price was the $40.20 closing price. Direct holdings following the transaction were 60,435 common shares; no Rule 10b5-1 plan is reported.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider Greenwald Taylor C
Role Chief Financial Officer
Type Security Shares Price Value
Tax Withholding Common Shares F1, F2 3,293 $40.20 $132K
Holdings After Transaction: Common Shares — 60,435 shares (Direct)
Footnotes (2)
  1. F1. Represents shares withheld for tax purposes upon vesting of restricted stock grant.
  2. F2. Closing price of Issuer's Common shares on September 18, 2026.
Shares withheld for taxes 3,293 shares Upon vesting of a restricted stock grant on September 18, 2026
Closing price $40.20 per share September 18, 2026
Direct holdings after transaction 60,435 common shares Following the September 18, 2026 transaction
restricted stock grant financial
"vesting of restricted stock grant"
A restricted stock grant is an award of company shares given to an employee or executive that cannot be sold or transferred until certain conditions are met, such as staying with the company for a set time or hitting performance goals. For investors, it signals how the company ties pay to future performance and can affect the number of shares outstanding and management’s incentives—think of it as a wrapped gift you only keep once you meet the requirements.
vesting financial
"upon vesting of restricted stock grant"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
closing price financial
"Closing price of Issuer's Common shares"
Rule 10b5-1 plan financial
"no Rule 10b5-1 plan is reported"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Who reported the IBEX (IBEX) share withholding?

Taylor C. Greenwald, IBEX Ltd’s Chief Financial Officer, reported the transaction.

How many IBEX shares were withheld, and why?

3,293 common shares were withheld for tax purposes upon vesting of a restricted stock grant on September 18, 2026.

What price was reported for the IBEX shares?

The reported price was $40.20 per share, identified as the closing price of IBEX Ltd common shares on September 18, 2026.

How many IBEX shares did Taylor C. Greenwald hold afterward?

The reported direct holdings following the transaction were 60,435 common shares.

Was the IBEX transaction reported under a Rule 10b5-1 plan?

No Rule 10b5-1 plan is reported for the transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Greenwald Taylor C

(Last)(First)(Middle)
C/O IBEX LIMITED
1717 PENNSYLVANIA AVENUE NW, SUITE 825

(Street)
WASHINGTON DISTRICT OF COLUMBIA 20006

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
IBEX Ltd [ IBEX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/18/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Shares09/18/2026F3,293(1)D$40.2(2)60,435D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents shares withheld for tax purposes upon vesting of restricted stock grant.
2. Closing price of Issuer's Common shares on September 18, 2026.
Remarks:
Lisa Lenstrohm, Attorney-in-Fact09/22/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading